SE430379B - Forfarande for framstellning av ett fast emne innehallande en mjolkdrygealkaloidkomponent - Google Patents

Forfarande for framstellning av ett fast emne innehallande en mjolkdrygealkaloidkomponent

Info

Publication number
SE430379B
SE430379B SE7611189A SE7611189A SE430379B SE 430379 B SE430379 B SE 430379B SE 7611189 A SE7611189 A SE 7611189A SE 7611189 A SE7611189 A SE 7611189A SE 430379 B SE430379 B SE 430379B
Authority
SE
Sweden
Prior art keywords
preparing
procedure
solid substance
substance containing
alkaloid component
Prior art date
Application number
SE7611189A
Other languages
English (en)
Swedish (sv)
Other versions
SE7611189L (sv
Inventor
L Ehrhardt
V Hartmann
L Patt
K-H Otto
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7611189L publication Critical patent/SE7611189L/
Publication of SE430379B publication Critical patent/SE430379B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7611189A 1975-10-17 1976-10-08 Forfarande for framstellning av ett fast emne innehallande en mjolkdrygealkaloidkomponent SE430379B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (2)

Publication Number Publication Date
SE7611189L SE7611189L (sv) 1977-04-18
SE430379B true SE430379B (sv) 1983-11-14

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7611189A SE430379B (sv) 1975-10-17 1976-10-08 Forfarande for framstellning av ett fast emne innehallande en mjolkdrygealkaloidkomponent

Country Status (28)

Country Link
JP (1) JPS5854122B2 (xx)
AT (1) AT362510B (xx)
AU (1) AU508628B2 (xx)
BE (1) BE847368A (xx)
CA (1) CA1079641A (xx)
CH (1) CH643737A5 (xx)
CS (1) CS199647B2 (xx)
DE (1) DE2546577B2 (xx)
DK (1) DK146194C (xx)
ES (1) ES452420A1 (xx)
FI (1) FI762875A (xx)
FR (1) FR2327764A1 (xx)
GB (1) GB1560406A (xx)
GR (1) GR61268B (xx)
HK (1) HK3183A (xx)
HU (1) HU172533B (xx)
IE (1) IE43778B1 (xx)
IL (1) IL50686A (xx)
MY (1) MY8400063A (xx)
NL (1) NL184558C (xx)
NO (1) NO144468C (xx)
NZ (1) NZ182341A (xx)
PH (1) PH14513A (xx)
PT (1) PT65719B (xx)
SE (1) SE430379B (xx)
SG (1) SG63082G (xx)
SU (1) SU1165223A3 (xx)
ZA (1) ZA766166B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
ATE72111T1 (de) * 1987-01-14 1992-02-15 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
MY126580A (en) * 1997-12-22 2006-10-31 Merck Sharp & Dohme Molecular dispersion composition with enchanced bioavailabity
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
ES2236017T3 (es) * 1999-12-03 2005-07-16 Polichem S.A. Procedimientos para la prepaaraciones farmaceuticas de liberacion sostenida de alcaloides del ergot que tienen biodfisponibilidad mejorada y composiciones de los mismos.
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US20060141038A1 (en) * 2003-06-27 2006-06-29 Bioprogress S. P. A. Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
DE2546577A1 (de) 1977-04-21
AT362510B (de) 1981-05-25
SE7611189L (sv) 1977-04-18
NL184558C (nl) 1989-09-01
FR2327764B1 (xx) 1979-03-02
AU508628B2 (en) 1980-03-27
SG63082G (en) 1983-09-09
ATA767976A (de) 1980-10-15
HK3183A (en) 1983-01-20
PT65719A (fr) 1976-11-01
NO144468C (no) 1981-09-09
SU1165223A3 (ru) 1985-06-30
AU1875476A (en) 1978-04-20
PT65719B (fr) 1978-06-12
IL50686A (en) 1979-05-31
JPS5854122B2 (ja) 1983-12-02
NZ182341A (en) 1978-09-20
NL7611295A (nl) 1977-04-19
FR2327764A1 (fr) 1977-05-13
GR61268B (en) 1978-10-17
CS199647B2 (en) 1980-07-31
NL184558B (nl) 1989-04-03
CA1079641A (en) 1980-06-17
PH14513A (en) 1981-08-24
MY8400063A (en) 1984-12-31
HU172533B (hu) 1978-09-28
DK146194B (da) 1983-07-25
ES452420A1 (es) 1978-04-16
NO144468B (no) 1981-06-01
DE2546577B2 (de) 1981-04-02
DK454176A (da) 1977-04-18
IL50686A0 (en) 1976-12-31
CH643737A5 (en) 1984-06-29
GB1560406A (en) 1980-02-06
ZA766166B (en) 1978-05-30
DK146194C (da) 1984-01-02
IE43778B1 (en) 1981-05-20
JPS5251014A (en) 1977-04-23
NO763446L (xx) 1977-04-19
FI762875A (xx) 1977-04-18
BE847368A (fr) 1977-04-15
IE43778L (en) 1977-04-17

Similar Documents

Publication Publication Date Title
SE430379B (sv) Forfarande for framstellning av ett fast emne innehallande en mjolkdrygealkaloidkomponent
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
NO140323C (no) Fremgangsmaate for fremstilling av et toert for for selskapsdyr
SE431456B (sv) Analogiforfarande for framstellning av kondenserade kinazolonderivat
SE422400B (sv) Forfarande for framstellning av ett vattenhaltigt sterkelsekoncentrat
SE448790B (sv) Forfarande for framstellning av ett dokument
IT1070586B (it) Procedimento per preparare poliolefine
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
DK517776A (da) Fremgangsmade til femstilling af heterocycliske forbindelser
SE7607565L (sv) Forfarande for framstellning av ett antidepressivum
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7613973L (sv) Forfarande for framstellning av pappersmassa
SE416479B (sv) Forfarande for framstellning av hogrena alkolimetallhalogenidkristaller
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE422205B (sv) Forfarande for framstellning av 1-karbamoyl-5-fluoruracil derivat
MX3904E (es) Procedimiento para preparar compuestos heterociclicos
NO146713C (no) Fremgangsmaate for fremstilling av en vaskepulverblanding
SE7605751L (sv) Forfarande for framstellning av en bensotiazinforening
DK154606C (da) Fremgangsmaade til fremstilling af en stabil oploesning af et hydrogeneret meldroejealkaloid
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE415097B (sv) Forfarande for framstellning av en 4-(hudroximetyl)imidazolforening

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7611189-7

Effective date: 19920510

Format of ref document f/p: F